In addition, both TSA [8] and valproic acid [9] HDAC inhibitors improve morphology and function of skeletal muscle in DMD mouse models - positive effects accredited to the upregulation of follistatin or Akt signaling pathways, respectively. This evidence concerns the gene HDAC9 and Duchenne muscular dystrophy.